EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
147 hedge funds and large institutions have $1.36B invested in Eagle Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
3.66%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
26
Increased
51
Reduced
49
Closed
22
Calls
$12.2M
Puts
$3.85M
Net Calls
+$8.31M
Net Calls Change
+$6.08M
Top Buyers
Top Sellers
1 |
PA
Perceptive Advisors
New York
|
-$39.5M |
2 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$24.9M |
3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$17.4M |
4 |
CM
Castleark Management
Chicago,
Illinois
|
-$9.25M |
5 |
Citadel Advisors
Miami,
Florida
|
-$8.8M |